Advanz Pharma Germany GmbH secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient lanreotide ATC H01CB03 for the period 01072025 - 30062026 plus extension option 1x 12 months

Germany, June 1 -- Germany based Advanz Pharma Germany GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Sec... और पढ़ें

Vifor Pharma Deutschland secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient iron parenteral preparations ATC B03AC01 f d Z 011125-311027 plus extension option 1x12 months

Germany, June 1 -- Germany based Vifor Pharma Deutschland has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Secti... और पढ़ें

ratiopharm GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient diclofenac exclusively GEL 25 g ATC D11AX18 for the period 01042025 - 31032027

Germany, June 1 -- Germany based ratiopharm GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a... और पढ़ें

Gedeon Richter Pharma GmbH secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Ganirelix ATC H01CC01 for the period 01062024 - 31052026

Germany, June 1 -- Germany based Gedeon Richter Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Sec... और पढ़ें

Bodensee Pharma GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient bexarotene ATC L01XF03 for the period 01062024 - 31052026

Germany, June 1 -- Germany based Bodensee Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section... और पढ़ें

Viatris Healthcare GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient formoterol beclometasone exclusively Dafo DOS ATC R03AK08 for the period 01012026 - 31032026

Germany, June 1 -- Germany based Viatris Healthcare GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Sect... और पढ़ें

Orifarm GmbH secures contract for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Fondaparinux ATC B01AX05 for the period 01062024 - 31052026

Germany, June 1 -- Germany based Orifarm GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Pa... और पढ़ें

Heumann Pharma GmbH & Co. Generika KG secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient colchicine ATC M04AC01 for the period 01082025 - 31072027 plus extension option 1x12 months

Germany, June 1 -- Germany based Heumann Pharma GmbH & Co. Generika KG has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in acco... और पढ़ें

Boehringer Ingelheim Pharma GmbH & Co. KG secures contract for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient tiotropium olodaterol ATC R03AL06 for the period 01062024 - 31052026

Germany, June 1 -- Germany based Boehringer Ingelheim Pharma GmbH & Co. KG has secured contract from DAK-Gesundheit for Pharmaceutical products - Conclusion of a non-exclusive discount agreement i... और पढ़ें

Thea Pharma GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Latanoprost exclusively single doses ATC S01EE01 for the period 01062025 - 31052027

Germany, June 1 -- Germany based Thea Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130... और पढ़ें

• ««
• «
• 9927
• 9928
• 9929
• 9930
• 9931
• 9932
• 9933
• 9934
• 9935
• 9936
• »
• »»